Matthew Bienick is a seasoned researcher with expertise in protein engineering and molecular biology. Currently serving as a Research Advisor at Eli Lilly and Company since June 2022, Matthew previously held the position of Molecular and Cell Biology Research Scientist at Vertex Pharmaceuticals from April 2020 to May 2022, where significant contributions included developing selection systems for therapeutic proteins and executing genome-wide CRISPR screens to advance gene therapy efforts. Earlier experience as a Graduate Research Assistant at the University of Arizona from September 2014 to December 2019 involved engineering allosteric control of kinases and phosphatases and designing protein-protein interactions using phage display techniques. Matthew holds a Bachelor of Science in Chemical Engineering from Michigan State University and a Doctor of Philosophy in Biochemistry from the University of Arizona.
This person is not in the org chart
This person is not in any teams
This person is not in any offices